Literature DB >> 20004218

Early behavioural markers of disease in P301S tau transgenic mice.

Maria Luisa Scattoni1, Laura Gasparini, Enrico Alleva, Michel Goedert, Gemma Calamandrei, Maria Grazia Spillantini.   

Abstract

The present study aimed at characterizing the early behavioural changes preceding the onset of disease in a transgenic mouse model of tauopathy. Mice transgenic for human P301S tau protein exhibit many characteristics of human tauopathies, including neurodegeneration, the formation of neuronal tau inclusions in the brain and the development of a pronounced motor phenotype by 5 months of age. In this study we analyzed the ultrasonic vocalization pattern in the first week of life and the response to nest-related olfactory stimuli on postnatal day 10 in both homozygous and heterozygous transgenic mice in comparison with the behavioural responses of C57BL/6J pups. Expression of human tau in the brain and spinal cord was evaluated by Western blot analysis. Homozygous P301S tau transgenic and C57BL/6J mice were also assessed for motor coordination in the Rotarod apparatus at 1, 2, 3 and 4 months of age, and spatial learning and spontaneous behaviour were evaluated at 2 months in the Morris water-maze and the open-field test. Results showed that P301S pups emitted more ultrasounds than C57BL/6J pups when separated from the mother. Two-month-old P301S mice displayed a hyperactive profile, as shown by increased swimming speed, enhanced locomotion and exploration of a novel object in the open field. However, the spatial task acquisition was unaltered. Decline of motor coordination capacities was evident only by the third month of age in the rotarod test. Behavioural abnormalities can be detected well before occurrence of neurodegeneration in this transgenic strain, thus representing precocious markers of pathology. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004218     DOI: 10.1016/j.bbr.2009.12.002

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  33 in total

Review 1.  Mechanisms of neural and behavioral dysfunction in Alzheimer's disease.

Authors:  Daniel W Wesson; Ralph A Nixon; Efrat Levy; Donald A Wilson
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

2.  Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.

Authors:  Chunxing Yang; Hongyan Wang; Tao Qiao; Bin Yang; Leonardo Aliaga; Linghua Qiu; Weijia Tan; Johnny Salameh; Diane M McKenna-Yasek; Thomas Smith; Lingtao Peng; Melissa J Moore; Robert H Brown; Huaibin Cai; Zuoshang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

3.  Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia N Starkova; Lichuan Yang; Anatoly A Starkov; Flint Beal
Journal:  FASEB J       Date:  2011-08-08       Impact factor: 5.191

4.  Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.

Authors:  E Fiori; L Babicola; D Andolina; A Coassin; T Pascucci; L Patella; Y-C Han; A Ventura; R Ventura
Journal:  Behav Genet       Date:  2015-05-31       Impact factor: 2.805

5.  Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.

Authors:  Michael A Kelberman; Claire R Anderson; Eli Chlan; Jacki M Rorabaugh; Katharine E McCann; David Weinshenker
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

6.  Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia Starkova; Noel Y Calingasan; Lichuan Yang; Davide Tampellini; Anatoly A Starkov; Robin B Chan; Gilbert Di Paolo; Aurora Pujol; M Flint Beal
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

7.  Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.

Authors:  Ann Van der Jeugd; Katja Hochgräfe; Tariq Ahmed; Jochen M Decker; Astrid Sydow; Anne Hofmann; Dan Wu; Lars Messing; Detlef Balschun; Rudi D'Hooge; Eva-Maria Mandelkow
Journal:  Acta Neuropathol       Date:  2012-04-25       Impact factor: 17.088

8.  P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating.

Authors:  Hiroki Takeuchi; Michiyo Iba; Haruhisa Inoue; Makoto Higuchi; Keizo Takao; Kayoko Tsukita; Yoshiko Karatsu; Yumiko Iwamoto; Tsuyoshi Miyakawa; Tetsuya Suhara; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

9.  Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.

Authors:  Nadia Mazzaro; Erica Barini; Maria Grazia Spillantini; Michel Goedert; Paolo Medini; Laura Gasparini
Journal:  J Neurosci       Date:  2016-02-17       Impact factor: 6.167

10.  Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.

Authors:  Manuela Mellone; Dimitra Kestoras; Melissa R Andrews; Elisa Dassie; R Anthony Crowther; Gorazd B Stokin; Jon Tinsley; Graeme Horne; Michel Goedert; Aviva M Tolkovsky; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.